Skip to main content

Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001744659

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Members of Congress who traded AKRO

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
1 / 0
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded AKRO
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Chris JacobsRepublican · House · NY11 / 0$8.00KNov 8, 2022Dec 12, 2022

Trades

Every reported trade in Akero Therapeutics, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Chris JacobsRepublican · House · NYAKROAkero Therapeutics, Inc.BuySelfNov 8, 2022Dec 12, 202234 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.